Note: Ingredients listed on restricted chemical lists
EC/CAS
259-174-3/54464-57-2
Name of the chemical
1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one (40)
Concentration
N/A
EC/CAS
259-175-9/54464-59-4
Name of the chemical
1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one (40)
Concentration
N/A
EC/CAS
268-978-3/68155-66-8
Name of the chemical
1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one (40)
Concentration
10-<20%
EC/CAS
268-979-9/68155-67-9
Name of the chemical
1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one; 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthyl)ethan-1-one (40)
Concentration
N/A
EC/CAS
233-732-6/78-70-6
Name of the chemical
1,6-Octadien-3-ol, 3,7-dimethyl
Concentration
5-<10%
EC/CAS
243-718-1/8000-41-7
Name of the chemical
2-(4-methylcyclohex-3-en-1-yl)propan-2-ol; p-Menth-1-en-8-ol (alpha-Terpineol); 1-methyl-4-(1-methylvinyl)cyclohexan-1-ol (beta-Terpineol); 1-methyl-4-(1-methylethylidene)cyclohexan-1-ol (gamma-Terpineol) (40)
Concentration
1-<5%
EC/CAS
205-399-7/118-58-1
Name of the chemical
Benzyl salicylate
Concentration
1-<5%
EC/CAS
200-945-0/76-22-2
Name of the chemical
camphor
Concentration
0.1-<1%
EC/CAS
208-898-8/106-22-9
Name of the chemical
Citronellol/ (±) 3,7-Dimethyl-6-octen-1-ol
Concentration
0.1-<1%
EC/CAS
203-375-0/1117-61-9
Name of the chemical
(3R)-3,7-dimethyloct-6-en-1-ol
Concentration
= 10
EC/CAS
205-473-9/7540-51-4
Name of the chemical
(3S)-3,7-dimethyloct-6-en-1-ol
Concentration
N/A
EC/CAS
231-415-7/68901-15-5
Name of the chemical
Allyl cyclohexyloxyacetate
Concentration
N/A
EC/CAS
203-161-7/80-56-8
Name of the chemical
α-pinene
Concentration
0.1-<1%
EC/CAS
200-945-0/464-49-3
Name of the chemical
Bornan-2-one; 1,7,7-Trimethylbi-cyclo[2.2.1]-2-heptanone (40)
Concentration
N/A
EC/CAS
207-355-2/21368-68-3
Name of the chemical
Bornan-2-one; 1,7,7-Trimethylbi-cyclo[2.2.1]-2-heptanone (40)
Concentration
0.1-<1%
EC/CAS
244-350-4/464-48-2
Name of the chemical
Bornan-2-one; 1,7,7-Trimethylbi-cyclo[2.2.1]-2-heptanone (40)
Concentration
N/A
EC/CAS
207-354-7/84-66-2
Name of the chemical
Diethyl phthalate (DEP),5
Concentration
N/A
EC/CAS
201-134-4
Name of the chemical
1,6-Octadien-3-ol, 3,7-dimethyl
Concentration
1-<5% 7,8-
EC/CAS
214-946-9
Name of the chemical
Galaxolide
Concentration
8,8- 1-<5%
EC/CAS
232-268-1
Name of the chemical
2-(4-methylcyclohex-3-en-1-yl)propan-2-ol; p-Menth-1-en-8-ol (alpha-Terpineol); 1-methyl-4-(1-methylvinyl)cyclohexan-1-ol (beta-Terpineol); 1-methyl-4-(1-methylethylidene)cyclohexan-1-ol (gamma-Terpineol) (40)
Concentration
1-<5%
EC/CAS
204-262-9
Name of the chemical
Benzyl salicylate
Concentration
1-<5%
EC/CAS
214-250-5
Name of the chemical
(3R)-3,7-dimethyloct-6-en-1-ol
Concentration
N/A
EC/CAS
247-737-6
Name of the chemical
Citronellol/ (±) 3,7-Dimethyl-6-octen-1-ol
Concentration
0.1-<1%
EC/CAS
272-657-3
Name of the chemical
Allyl cyclohexyloxyacetate
Concentration
0.1-<1%
EC/CAS
201-291-9
Name of the chemical
2,6,6-Trimethylbi-cyclo[3.1.1]hept-2-ene (alpha-Pinene); 6,6-Dimethyl- 2-methylenebicyclo[3.1.1]heptane (beta-Pinene) (40) (41)
Concentration
0.1-<1%
EC/CAS
201-550-6
Name of the chemical
diethyl phthalate (DEP)
Concentration
20-<50%
General Information
Version
26
Revision date
2024-10-17
Product name
CHRISTMAS WREATH FRAGRANCE
Product Synonyms
None
1.2.1 Relevant identified uses
Fragrances
Emergency telephone
+44 1926 291009
Icons in SDS
Company Information
company name
Imperial Supply Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
support@craftovator.co.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H410
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Signal word
Warning
Hazard statements
H315, Causes skin irritation. H317, May cause an allergic skin reaction. H319, Causes serious eye irritation. H410, Very toxic to aquatic life with long lasting effects.
Additional information
EUH208, Contains 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, ALPHA- PINENES, BENZYL SALICYLATE, CITRONELLOL, CYCLAMEN ALDEHYDE, EUCALYPTOL. May produce an allergic reaction.
Precautionary statements
P261, Avoid breathing vapour or dust. P264, Wash hands and other contacted skin thoroughly after handling. P272, Contaminated work clothing should not be allowed out of the workplace. P273, Avoid release to the environment. P280, Wear protective gloves/eye protection/face protection. P302/352, IF ON SKIN: Wash with plenty of soap and water. P305/351/338, IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333/313, If skin irritation or rash occurs: Get medical advice/attention. P337/313, If eye irritation persists: Get medical advice/attention. P362, Take off contaminated clothing and wash before reuse. P391, Collect spillage. P501, Dispose of contents/container to approved disposal site, in accordance with local regulations.
Other hazards
Sensitisers declared on a CLP 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, Hazard Label: ALPHA-PINENES, BENZYL SALICYLATE, CITRONELLOL, CYCLAMEN ALDEHYDE, EUCALYPTOL Hydrocarbon Concentration %: 1.012%
2.1 Classification of the substance or mixture
Classification under Regulation (EC) No 1272/2008 Class and category of Skin Corrosion / Irritation Category 2 danger: Eye Damage / Irritation Category 2 Sensitization - Skin Category 1 Hazardous to the Aquatic Environment - Long-term Hazard Category 1 H315, Causes skin irritation. H317, May cause an allergic skin reaction. H319, Causes serious eye irritation. H410, Very toxic to aquatic life with long lasting effects. 26 2.2 Label elements Classification under Regulation (EC) No 1272/2008 Signal word: Warning Hazard statements: H315, Causes skin irritation. H317, May cause an allergic skin reaction. H319, Causes serious eye irritation. H410, Very toxic to aquatic life with long lasting effects. Supplemental EUH208, Contains 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, ALPHA- Information: PINENES, BENZYL SALICYLATE, CITRONELLOL, CYCLAMEN ALDEHYDE, EUCALYPTOL. May produce an allergic reaction. Precautionary P261, Avoid breathing vapour or dust. statements: P264, Wash hands and other contacted skin thoroughly after handling. P272, Contaminated work clothing should not be allowed out of the workplace. P273, Avoid release to the environment. P280, Wear protective gloves/eye protection/face protection. P302/352, IF ON SKIN: Wash with plenty of soap and water. P305/351/338, IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333/313, If skin irritation or rash occurs: Get medical advice/attention. P337/313, If eye irritation persists: Get medical advice/attention. P362, Take off contaminated clothing and wash before reuse. P391, Collect spillage. P501, Dispose of contents/container to approved disposal site, in accordance with local regulations. Pictograms: 2.3 Other hazards Other hazards: Sensitisers declared on a CLP 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, Hazard Label: ALPHA-PINENES, BENZYL SALICYLATE, CITRONELLOL, CYCLAMEN ALDEHYDE, EUCALYPTOL Hydrocarbon Concentration %: 1.012% 26 Section 3. Composition / information on ingredients 3.2 Mixtures Contains: Name Specific Conc. CAS EC REACH Registration % Classification for Limits, M-factors No. (CLP) 1272/2008 and ATEs 259-174-3, 54464-57-2, TETRAMETHYL 54464-59-4, 259-175-9, SCI 2-SS 1B-EH C1; ACETYLOCTAHYDRON 68155-66-8, 268-978-3, 01-2119489989-04-xxxx 10-<20% H315-H317-H410,- APHTHALENES 268-979-9, 68155-67-9 915-730-3 ETHYL LINALOOL 10339-55-6 233-732-6 01-2119969272-32-xxxx 5-<10% SCI 2-EDI 2-SS 1B; oral: ATE = 5000 H315-H317-H319,- mg/kg bw LINALOOL 78-70-6 201-134-4 01-2119474016-42-xxxx 1-<5% SCI 2-EDI 2-SS 1B; oral: ATE = 2790 H315-H317-H319,- mg/kg bw 1,3,4,6,7,8- HEXAHYDRO- 4,6,6,7,8,8- 1222-05-5 214-946-9 01-2119488227-29-xxxx 1-<5% EH A1-EH C1;H410,- HEXAMETHYLINDENO [5,6-C]PYRAN 4-TERT- oral: ATE = 3370 BUTYLCYCLOHEXYL 32210-23-4 250-954-9 01-2119976286-24-xxxx 1-<5% SS 1B;H317,- mg/kg bw ACETATE TETRAHYDRO- METHYL- 63500-71-0 405-040-6 01-0000015458-64-xxxx 1-<5% EDI 2;H319,- (METHYLPROPYL)- PYRAN-4-OL CIS-2-TERT- oral: ATE = 4600 BUTYLCYCLOHEXYL 20298-69-5 243-718-1 01-2119970713-33-xxxx 1-<5% EH C2;H411,- mg/kg bw ACETATE TERPINEOL 8000-41-7 232-268-1 01-2119553062-49-xxxx 1-<5% SCI 2-EDI 2;H315- oral: ATE = 4300 H319,- mg/kg bw BENZYL ACETATE 140-11-4 205-399-7 1-<5% EH C3;H412,- oral: ATE = 2490 mg/kg bw BENZYL SALICYLATE 118-58-1 204-262-9 1-<5% SS 1B-EH C3;H317- oral: ATE = 2200 H412,- mg/kg bw dermal: ATE = 3100 PHENYLISOXANOL 55066-48-3 259-461-3 01-2119969446-23-xxxx 1-<5% ATO 4;H302,- mg/kg bw-oral: ATE = 1830 mg/kg bw ALPHA-CEDRENE 469-61-4 207-418-4 0.1-<1% SCI 2-AH 1-EH A1-EH M = 10-M = 10 C1;H304-H315-H410,- 3-(2H-1,3- SS 1B-REP 2-EH C2; oral: ATE = 3562 BENZODIOXOL-5-YL) 1205-17-0 214-881-6 01-2120740119-58-xxxx 0.1-<1% H317-H361-H411,- mg/kg bw -2-METHYLPROPANAL 4-METHYL-3-DECEN-5- 81782-77-6 279-815-0 01-2119983528-21-xxxx 0.1-<1% EH A1-EH C2;H400- OL H411,- EUCALYPTOL 470-82-6 207-431-5 0.1-<1% FL 3-SS 1B;H226- oral: ATE = 2480 H317,- mg/kg bw FS 2-ATO 4-ATI 4-SCI inhalation: ATE = 1.5 2-EDI 1-STO-SE 2-EH mg/l (dusts or mists)- CAMPHOR 76-22-2 200-945-0 0.1-<1% C2;H228-H302-H315- oral: ATE = 1500 H318-H332-H371- H411,- mg/kg bw BETA CEDRENE 546-28-1 208-898-8 0.1-<1% AH 1-EH A1-EH C1; M = 10-M = 10 H304-H410,- 26 106-22-9, 203-375-0, 1117-61-9, 214-250-5, 26489-01-0, 247-737-6, SCI 2-EDI 2-SS 1B; dermal: ATE = 2650 CITRONELLOL 6812-78-8, 229-887-4, 01-2119453995-23-xxxx 0.1-<1% H315-H317-H319,- mg/kg bw-oral: ATE = 3450 mg/kg bw 141-25-3, 205-473-9, 7540-51-4 231-415-7 ALLYL ATO 4-EH A1-EH C1; oral: ATE = 682 mg/kg CYCLOHEXYLOXYACE 68901-15-5 272-657-3 0.1-<1% H302-H410,- bw TATE CYCLAMEN 103-95-7 203-161-7 01-2119970582-32-xxxx 0.1-<1% SCI 2-SS 1B-EH C3; oral: ATE = 3810 ALDEHYDE H315-H317-H412,- mg/kg bw FL 3-ATO 4-SCI 2-SS ALPHA-PINENES 80-56-8 201-291-9 0.1-<1% 1B-AH 1-EH A1-EH oral: ATE = 500 mg/kg C1;H226-H302-H304- bw H315-H317-H410,- Substances with Community workplace exposure limits: Name Specific Conc. CAS EC REACH Registration % Classification for Limits, M-factors No. (CLP) 1272/2008 and ATEs 76-22-2, 200-945-0, CAMPHOR 464-49-3, 207-355-2, 0.1-<1% -;-,- 21368-68-3, 244-350-4, 464-48-2 207-354-7 DIETHYL PHTHALATE 84-66-2 201-550-6 01-2119486682-27-xxxx 20-<50% -;-,- Substances that are endocrine disruptors according to Regulation (EU) 2017/2100 or Regulation (EU) 2018/605, greater than 0.1%: Not Applicable Substances that are persistent, bioaccumulative and toxic or very persistent and very bioaccumulative, greater than 0.1%: Not Applicable Section 4. First-aid measures 4.1 Description of first aid measures Inhalation: Remove from exposure site to fresh air, keep at rest, and obtain medical attention. Eye exposure: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Skin exposure: IF ON SKIN: Wash with plenty of soap and water. Ingestion: Rinse mouth with water and obtain medical attention. 4.2 Most important symptoms and effects, both acute and delayed Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. 4.3 Indication of any immediate medical attention and special treatment needed None expected, see Section 4.1 for further information. 26